These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 25440)

  • 21. Role of different normal hematopoietic regulatory proteins in the differentiation of myeloid leukemic cells.
    Lotem J; Shabo Y; Sachs L
    Int J Cancer; 1988 Jan; 41(1):101-7. PubMed ID: 3257207
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo induction of normal differentiation in myeloid leukemia cells.
    Lotem J; Sachs L
    Proc Natl Acad Sci U S A; 1978 Aug; 75(8):3781-5. PubMed ID: 308656
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of normal differentiation in mouse and human myeloid leukemic cells by phorbol esters and the mechanism of tumor promotion.
    Lotem J; Sachs L
    Proc Natl Acad Sci U S A; 1979 Oct; 76(10):5158-62. PubMed ID: 291929
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ectopic beta-adrenergic receptor binding sites. possible molecular basis of aberrant catecholamine responsiveness of an adrenocortical tumor adenylate cyclase.
    Williams LT; Gore TB; Lefkowitz RJ
    J Clin Invest; 1977 Feb; 59(2):319-24. PubMed ID: 13086
    [TBL] [Abstract][Full Text] [Related]  

  • 25. beta-Adrenergic receptor desensitization in rat adipocyte membranes.
    Giudicelli Y; Agli B; Lacasa D
    Biochim Biophys Acta; 1979 Jun; 585(1):85-93. PubMed ID: 221051
    [No Abstract]   [Full Text] [Related]  

  • 26. Catecholamine hormone receptor differences identified on 3T3 and simian virus-transformed 3T3 cells.
    Sheppard JR
    Proc Natl Acad Sci U S A; 1977 Mar; 74(3):1091-4. PubMed ID: 15252
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of adenylyl cyclase activity by beta-adrenergic agonists in a desensitization-resistant mutant cell line.
    Olson MF; Tsao J; Pon DJ; Schimmer BP
    Mol Endocrinol; 1991 Jan; 5(1):34-41. PubMed ID: 1850109
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Control of normal differentiation of myeloid leukemic cells to macrophages and granulocytes.
    Fibach E; Hayashi M; Sachs L
    Proc Natl Acad Sci U S A; 1973 Feb; 70(2):343-6. PubMed ID: 4510279
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Uncoupling of the beta-adrenergic receptor as a mechanism of in vitro neutrophil desensitization.
    Galant SP; Britt S
    J Lab Clin Med; 1984 Feb; 103(2):322-32. PubMed ID: 6319518
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional alteration of the beta-adrenergic receptor during desensitization of mammalian adenylate cyclase by beta-agonists.
    Kassis S; Fishman PH
    Proc Natl Acad Sci U S A; 1984 Nov; 81(21):6686-90. PubMed ID: 6093112
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phosphorylation/dephosphorylation of the beta-adrenergic receptor regulates its functional coupling to adenylate cyclase and subcellular distribution.
    Sibley DR; Strasser RH; Benovic JL; Daniel K; Lefkowitz RJ
    Proc Natl Acad Sci U S A; 1986 Dec; 83(24):9408-12. PubMed ID: 3025843
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Beta-adrenoceptor desensitization in rat lung: functional and biochemical aspects.
    Abbracchio MP; Cattabeni F; Coen E; Torres-Hernandez Y; Omini C
    Eur J Pharmacol; 1983 Apr; 89(1-2):35-42. PubMed ID: 6305685
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Desensitization of adenylate cyclase and down regulation of beta adrenergic receptors after in vivo administration of beta agonist.
    Scarpace PJ; Abrass IB
    J Pharmacol Exp Ther; 1982 Nov; 223(2):327-31. PubMed ID: 6127402
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Agonist-induced increase in apparent beta-adrenergic receptor size.
    Limbird LE; Lefkowitz RJ
    Proc Natl Acad Sci U S A; 1978 Jan; 75(1):228-32. PubMed ID: 24213
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Desensitization of beta adrenergic receptors linked to adrenocorticotropin secretion.
    Reisine T; Heisler S
    J Pharmacol Exp Ther; 1983 Oct; 227(1):107-14. PubMed ID: 6137552
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Different blocks in the differentiation of myeloid leukemic cells.
    Lotem J; Sachs L
    Proc Natl Acad Sci U S A; 1974 Sep; 71(9):3507-11. PubMed ID: 4530318
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mepacrine blocks beta-adrenergic agonist-induced desensitization in astrocytoma cells.
    Mallorga P; Tallman JF; Henneberry RC; Hirata F; Strittmatter WT; Axelrod J
    Proc Natl Acad Sci U S A; 1980 Mar; 77(3):1341-5. PubMed ID: 6246490
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of L-triiodothyronine on (--)3H-dihydroalprenolol binding and cyclic AMP response to (--)adrenaline in cultured heart cells.
    Tsai JS; Chen A
    Nature; 1978 Sep; 275(5676):138-40. PubMed ID: 211424
    [No Abstract]   [Full Text] [Related]  

  • 39. Induction of functional beta-adrenergic receptors in HeLa cells.
    Tallman JF; Smith CC; Henneberry RC
    Proc Natl Acad Sci U S A; 1977 Mar; 74(3):873-7. PubMed ID: 191837
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship between beta-adrenergic receptors and adenylate cyclase in HeLa cells.
    Henneberry RC; Smith CC; Tallman JF
    Nature; 1977 Jul; 268(5617):252-4. PubMed ID: 196205
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.